Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10838151 | Pharmacology Biochemistry and Behavior | 2011 | 7 Pages |
Abstract
⺠We compared the spinal effects of N-arachidonoyl-dopamine (NADA) with endomorphin-1. ⺠NADA had lower potency than endomorhin-1. ⺠The antinociceptive effect NADA is due to spinal TRPV1 and CB1 receptors. ⺠The interaction of NADA and endomorphin-1 was additive.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Ibolya Farkas, Gabor Tuboly, Gyorgy Benedek, Gyongyi Horvath,